CareRx Corporation (TSX:CRRX)
Canada · Delayed Price · Currency is CAD 3.180
-0.070 (-2.15%)
Jun 1, 2026, 3:59 PM EST
CareRx Cash Flow Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 27.07 | 26.13 | -4.5 | -5.41 | -34.35 | -22.73 |
Depreciation & Amortization | 18.1 | 18.33 | 19.19 | 19.98 | 20.07 | 15.39 |
Stock-Based Compensation | 2.75 | 2.72 | 3.65 | 1.47 | 4.57 | 2.67 |
Other Adjustments | 7.14 | -15.37 | 10.53 | 9.23 | 31.2 | 15.9 |
Change in Receivables | 0.56 | - | - | - | - | - |
Changes in Inventories | 1.48 | - | - | - | - | - |
Changes in Accounts Payable | -3.91 | - | - | - | - | - |
Changes in Income Taxes Payable | - | - | 0.14 | -0.02 | 0.5 | -0.23 |
Changes in Other Operating Activities | -1.82 | -0.99 | 8.98 | 2.12 | 0.36 | -3.73 |
Operating Cash Flow | 30.37 | 30.81 | 37.99 | 27.38 | 22.33 | 7.27 |
Operating Cash Flow Growth | -15.86% | -18.89% | 38.78% | 22.58% | 207.24% | 3074.24% |
Capital Expenditures | -5.55 | -5.59 | -5.59 | -4.73 | -10.04 | -5.35 |
Sale of Property, Plant & Equipment | 0.04 | 0.04 | 0.2 | 0.04 | 0 | 0.07 |
Purchases of Intangible Assets | -2.79 | -2.71 | -2.53 | -3.97 | -3.57 | -1.77 |
Payments for Business Acquisitions | - | - | - | -3.66 | -2.99 | -86.13 |
Investing Cash Flow | -8.3 | -8.26 | -7.92 | -12.31 | -16.6 | -93.18 |
Short-Term Debt Repaid | - | - | -14 | - | - | - |
Net Short-Term Debt Issued (Repaid) | - | - | -14 | - | - | - |
Long-Term Debt Issued | 0.5 | 1 | 1.8 | 60.3 | - | 64.35 |
Long-Term Debt Repaid | -5.13 | -5.32 | -3.53 | -94.18 | -0.04 | -30.42 |
Net Long-Term Debt Issued (Repaid) | -4.63 | -4.32 | -1.73 | -33.88 | -0.04 | 33.93 |
Issuance of Common Stock | 0.39 | 0.01 | - | 14.68 | 1.01 | 80.86 |
Repurchase of Common Stock | -2.44 | -2.24 | -0.8 | -0.06 | - | - |
Net Common Stock Issued (Repurchased) | -2.05 | -2.23 | -0.8 | 14.62 | 1.01 | 80.86 |
Common Dividends Paid | -1.26 | -1.26 | - | - | - | - |
Other Financing Activities | -8.99 | -9.92 | -11.49 | -17.14 | -13.96 | -12.88 |
Financing Cash Flow | -18.39 | -17.72 | -28.02 | -36.4 | -12.99 | 101.91 |
Net Cash Flow | 3.68 | 4.84 | 2.06 | -21.34 | -7.25 | 16 |
Free Cash Flow | 24.81 | 25.23 | 32.4 | 22.65 | 12.29 | 1.92 |
Free Cash Flow Growth | -1.65% | -22.14% | 43.08% | 84.26% | 540.82% | - |
FCF Margin | 6.62% | 6.81% | 8.84% | 6.11% | 3.22% | 0.73% |
Free Cash Flow Per Share | 0.38 | 0.39 | 0.54 | 0.39 | 0.26 | 0.06 |
Levered Free Cash Flow | 30.75 | 33.57 | 2.5 | -21.93 | -23.51 | 17.28 |
Unlevered Free Cash Flow | 71.55 | 90.56 | 27.28 | 19.98 | -10.12 | 2.91 |